Nursa vs Pfizer

Side-by-side comparison of AI visibility scores, market position, and capabilities

Pfizer leads in AI visibility (93 vs 52)
Nursa logo

Nursa

ChallengerHealthcare

Nurse & Clinician Staffing Platform

Nursa connects 400,000+ verified clinicians (RNs, LPNs, CNAs) with facilities for flexible PRN shifts; raised $103M (Series B led by Drive Capital); launched AI scheduling in September 2025; serves facilities nationwide.

AI VisibilityBeta
Overall Score
C52
Category Rank
#297 of 596
AI Consensus
81%
Trend
stable
Per Platform
ChatGPT
50
Perplexity
49
Gemini
52

About

Nursa is a Salt Lake City-based healthcare staffing platform that connects nurses and other healthcare professionals with hospitals, nursing homes, and care facilities that need short-term clinical staff. The platform offers verified clinicians — including Registered Nurses (RNs), Licensed Practical Nurses (LPNs), and Certified Nursing Assistants (CNAs) — the ability to browse and book PRN (as-needed) shifts on flexible schedules, giving them income control without the constraints of traditional agency placement. For facilities, Nursa provides on-demand access to a pool of over 400,000 verified, local clinicians to fill staffing gaps quickly and cost-effectively.

Full profile
Pfizer logo

Pfizer

LeaderHealthcare Tech

Enterprise

Global biopharma with $63.6B FY2024 revenue; $43B Seagen ADC acquisition rebuilds post-COVID pipeline; patent cliff 2026-2028 for Eliquis; activist Starboard Value pushing restructuring.

AI VisibilityBeta
Overall Score
A93
Category Rank
#1 of 596
AI Consensus
80%
Trend
stable
Per Platform
ChatGPT
94
Perplexity
89
Gemini
94

About

Pfizer is one of the world's largest biopharmaceutical companies, founded in 1849 by cousins Charles Pfizer and Charles Erhart in Brooklyn, New York, and now headquartered in New York City. The company trades on NYSE (PFE) and reported $63.6 billion in total revenues for FY2024, normalizing from pandemic highs of $100 billion-plus in 2021-2022 driven by Comirnaty COVID-19 vaccine revenues with BioNTech and Paxlovid COVID antiviral sales. CEO Albert Bourla has led a strategic pivot to reset the company's long-term growth profile, anchored by the landmark $43 billion acquisition of Seagen in December 2023, adding a world-class antibody-drug conjugate (ADC) oncology pipeline including Padcev, Tukysa, Adcetris, and Tivdak.

Full profile

AI Visibility Head-to-Head

52
Overall Score
93
#297
Category Rank
#1
81
AI Consensus
80
stable
Trend
stable
50
ChatGPT
94
49
Perplexity
89
52
Gemini
94
52
Claude
92
57
Grok
98

Key Details

Category
Nurse & Clinician Staffing Platform
Enterprise
Tier
Challenger
Leader
Entity Type
brand
company

Track AI Visibility in Real Time

Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.